Article Summary
Novo Nordisk has been swept up in uncertainty around U.S. tariffs and Washington's push to get firms to lower drug prices and move manufacturing stateside.
Read the Full Article
This is a summary from our news feed. For the complete article with full details, analysis, and additional content, visit the original source.
Read Full Article on CNBC MarketsAbout This Story
Published:September 1, 2025 at 01:10 PM
Source:CNBC Markets
Category:Trading
Reading Time:~2 min on source